Susceptibility of Helicobacter pylori to the bactericidal activity of human serum

Helicobacter

Volumn 1, Issue 1, 1996, Pages 28-33

  Gonzalez Valencia, Gerardo ^a,b   Perez Perez, Guillermo I ^a   Washburn, Ronald G ^c   Blaser, Martin J ^a,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BACTERIUM ANTIBODY; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3;

ARTICLE; CAMPYLOBACTER FETUS; COMPLEMENT ACTIVATION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; SERUM BACTERICIDAL ACTIVITY;

ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; CAMPYLOBACTER FETUS; COMPLEMENT ACTIVATION; COMPLEMENT C2; COMPLEMENT C3; COMPLEMENT FACTOR B; HELICOBACTER PYLORI; HUMANS;

EID: 0030088822     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1996.tb00005.x     Document Type: Article

References (20)

1. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94:4-8.
2. Ndawula EM, Owen RJ, Mihr G, Borman P, Hurtado A. Helicobacter pylori bacteraemia. Eur J Clin Microbiol Infect Dis 1994;13:621.
3. Roantree RJ, Pappas NC. The survival of strains of enteric bacilli in the blood stream as related to their sensitivity to the bactericidal effect of serum. J Clin Invest 1960;39:82-8.
4. Blaser MJ, Smith PF, Kohler PF. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis 1985;151:227-35.
5. Blaser MJ, Smith PF, Hopkins JA, Heinzer I, Bryner JH, Wang W.L.L. Pathogenesis of Campylobacter fetus infections. Serum resistance associated with high-molecular weight surface proteins. J Infect Dis 1987;155:696-709.
6. Tosi MF, Czinn SJ. Opsonic activity of specific human IgG against Helicobacter pylori. J Infect Dis 1990;162:156-62.
7. Korhonen H, Syvaoja EL, Ahola-Luttila H, Sivela S, Kapola S, Husu J, Kosunen TU. Bactericidal effect of bovine normal and immune serum colostrum and milk against Helicobacter pylori. J Appl Bacteriol 1995;78:655-62.
8. Cover TL, Blaser MJ. Purification and characterization of the vacuolizing toxin from Helicobacter pylori. J Biol Chem 1992;267:10570-5.
9. Cover TL, Dooley CP, Blaser MJ. Characterization of a human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990;58:603-10.
10. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 1993;61: 1799-809.
11. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988;109:11-7.
12. Blaser MJ, Smith PF, Repine JE, Joiner KA. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explain serum and phagocytosis resistance. J Clin Invest 1988;81:1434-44.
13. Joiner K A, Hammer CH, Brow EJ, Cole RJ, Frank MM. Studies on the mechanism of bacterial resistance to complement-mediated killing: I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. Exp Med 1982;155:797-808.
14. Atherton JC, Peek RM, Tham KT, Perez-Perez GI, Blaser MJ. Quantitative culture of Helicobacter pylori in the gastric antrum: Association of bacterial density with duodenal ulcer status and infection with cagA positive bacterial strains, and negative association with serum IgG levels [abstract]. Am J Gastroenterol 1994;89:147.
15. McKinlay AW, Young A, Rusell RI, Gemmel CG. Opsonic requirements of Helicobacter pylori. J Med Microbiol 1993;38:209-15.
16. Joiner KA, Goldman R, Shmetz M, Berger M, Hammer CH, Frank MM, Leive L. A quantitative analysis of C3 binding to Oantigen capsule lipopolysaccharide and outer membrane protein of E. Coli 0111B4. J Immunol 1984;132:369-75.
17. Perez-Perez GI, Blaser MJ. Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 1987; 55:1256-63.
18. Pangburn MK. Activation of complement via the alternative pathway. Fed Proc 1983;42:139-43.
19. Joiner KA, Hammer CH, Brown E, Frank MM. Studies on the mechanism of bacterial resistance to complement mediated killing: II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. J Exp Med 1982;155:809-19.
20. Morris AJ, Rafig AM, Nicholson GI, Perez-Perez GI, Blaser MJ. Long term follow up of voluntary ingestion of Helicobacter pylori. Ann Intern Med 1991;114:662-3.